Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 2,029 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,029 shares of the stock in a transaction on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $46,382.94. Following the sale, the chief operating officer now owns 754,903 shares in the company, valued at approximately $17,257,082.58. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Monday, April 8th, Evan Roberts sold 7,178 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total transaction of $162,366.36.
• On Thursday, March 21st, Evan Roberts sold 25,962 shares of Phreesia stock. The shares were sold at an average price of $23.52, for a total value of $610,626.24.

Phreesia Stock Performance

Phreesia stock opened at $23.16 on Thursday. The firm has a market capitalization of $1.31 billion, a PE ratio of -9.19 and a beta of 0.92. Phreesia, Inc. has a one year low of $12.05 and a one year high of $34.98. The stock’s 50 day moving average price is $24.49 and its 200 day moving average price is $21.25. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. The company had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The business’s quarterly revenue was up 24.0% on a year-over-year basis. During the same quarter last year, the firm posted ($0.72) earnings per share. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

PHR has been the subject of several analyst reports. Barclays began coverage on Phreesia in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $29.00 target price for the company. Raymond James reissued an “outperform” rating and issued a $30.00 target price (up from $25.00) on shares of Phreesia in a research report on Friday, March 15th. DA Davidson reaffirmed a “neutral” rating and set a $32.00 price target on shares of Phreesia in a research note on Friday, March 15th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Finally, Canaccord Genuity Group boosted their price target on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $31.62.

Hedge Funds Weigh In On Phreesia

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. WoodTrust Financial Corp lifted its stake in shares of Phreesia by 87.9% in the first quarter. WoodTrust Financial Corp now owns 31,000 shares of the company’s stock worth $742,000 after acquiring an additional 14,500 shares in the last quarter. Moody National Bank Trust Division raised its position in shares of Phreesia by 41.9% in the 1st quarter. Moody National Bank Trust Division now owns 71,044 shares of the company’s stock valued at $1,700,000 after purchasing an additional 20,977 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Phreesia by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after purchasing an additional 194,035 shares in the last quarter. American International Group Inc. boosted its stake in shares of Phreesia by 2.3% during the 4th quarter. American International Group Inc. now owns 26,342 shares of the company’s stock valued at $610,000 after buying an additional 591 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Phreesia by 56.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,595 shares of the company’s stock worth $1,728,000 after buying an additional 26,868 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.